Health
Take-at-home COVID drug molnupiravir may be on its way — but vaccination is still our first line of defence – The Conversation AU
Merck announced preliminary data suggesting the drug reduced the risk of hospitalisation and death by 50%.
The Australian government has pre-purchased 300,000 courses of an experimental antiviral oral drug called molnupiravir.
Interim results announced by the company, US pharmaceutical Merck, show the drug halved the number of patients who ended up in hospital…
Continue Reading
